# Option Care Health, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Option Care Health, Inc.). ## Overview Option Care Health is a U.S.-based provider of home and alternate-site infusion services delivered through a national network of locations. The company supplies infusion therapies, related pharmaceuticals, nursing support, and care coordination for patients with complex and chronic medical conditions, working under physician direction across the United States. ## Products & services • Home infusion therapy • Alternate-site infusion services • Pharmacy dispensing and compounded solutions • Nursing support and care coordination • Patient monitoring and adherence programs • Clinical support for complex chronic therapies - **Infusion therapy services** (70%) — Administration of intravenous therapies in patients' homes or other nonhospital settings. - **Pharmaceuticals and compounded solutions** (20%) — Medications and complex compounded products delivered as part of infusion care. - **Nursing and clinical support** (10%) — Nursing visits, care coordination, and therapy management tied to infusion treatment. - Home infusion therapy - Alternate-site infusion services - Pharmacy dispensing and compounded solutions - Nursing support and care coordination - Patient monitoring and adherence programs - Clinical support for complex chronic therapies ## Customers Option Care Health serves patients needing infusion treatment for acute and chronic conditions, with care coordinated through physicians and other referral sources. Its business also depends on managed care organizations, third-party payers, hospitals, and pharmaceutical manufacturers that influence patient access, reimbursement, and therapy distribution. - **Patients requiring infusion therapy** (primary) — Patients receiving IV therapies at home or other nonhospital settings for chronic and acute conditions. - **Managed care organizations and third-party payers** (primary) — Payers that authorize, reimburse, and steer patient access to home infusion services. - **Physicians and referral sources** (primary) — Physicians, discharge planners, and hospital staff that refer patients into the service network. - **Hospitals and health systems** (secondary) — Health systems that use the company for transitional and post-acute infusion care. - **Pharmaceutical manufacturers** (secondary) — Drug makers that rely on the company for distribution, launch support, and adherence programs. - Patients with complex chronic or acute infusion needs - Physicians and specialist practices referring patients - Managed care organizations and third-party payers - Hospitals and health systems managing post-acute transitions - Pharmaceutical manufacturers seeking distribution and adherence support ## Geography Option Care Health operates primarily in the United States through a national network of locations across many states. Its footprint is designed to support local patient access, payer relationships, and referral coverage, while keeping the business exposed to U.S. reimbursement, regulatory, and healthcare utilization trends. - **United States** (100%) — National U.S. home and alternate-site infusion network - Operations are concentrated in the United States - National network supports patient access across many states - Location footprint matters for referral coverage and service speed - U.S. payer and reimbursement rules shape economics - No country-level revenue disclosure was provided in the excerpts ## Strategy The company’s strategy centers on expanding relationships with drug manufacturers, managed care organizations, and referral sources to secure access to new therapies and patient volume. It also uses its national footprint and clinical capabilities to support complex therapies, improve adherence, and strengthen its position in post-acute and home-based care pathways. - **Maintain and expand manufacturer partnerships** (short-term) — Access to compatible therapies and launch opportunities supports patient volume and service breadth. - **Grow payer and referral network coverage** (medium-term) — Managed care and referral relationships determine patient access and service flow. - **Broaden complex therapy capabilities** (medium-term) — A wider therapy mix supports relevance across chronic and acute treatment categories. - Deepen manufacturer relationships for new product launches - Use national payer relationships to support referral pull-through - Expand clinical coverage for complex and chronic therapies - Strengthen hospital and health-system transition-of-care links - Leverage local field sales with national contracting ## Risks The business is exposed to payer reimbursement pressure, drug supply dependence, and concentration in managed care relationships, all of which can affect patient access and pricing. It also faces operational and compliance risks tied to cybersecurity, billing audits, inflation in labor and supplies, and the integration of acquisitions or strategic investments. - **Payer reimbursement pressure** [high] — Managed care organizations and government payers can reduce reimbursement rates or change coverage rules. - **Dependence on compatible pharmaceuticals** [high] — The business relies on manufacturers to supply drugs that fit home infusion administration requirements. - **Managed care concentration** [high] — Loss of key payer relationships could reduce patient referrals and access to covered lives. - **Cybersecurity and privacy incidents** [high] — The company stores protected health information and depends on secure IT systems for operations. - **Billing audits and compliance reviews** [medium] — Government and private payer audits can lead to adverse findings, repayments, or operational changes. - Reimbursement pressure from payers can reduce service economics - Drug supply shortages or recalls can disrupt therapy delivery - Managed care concentration can limit patient access and pricing power - Cybersecurity failures could expose patient data and disrupt operations - Billing audits and payer reviews can create repayment or compliance risk ## Accounting Revenue is recognized at estimated net realizable amounts from third-party payers and patients, with pharmaceuticals recognized on delivery and nursing services recognized as rendered. Investors should also watch estimates around accounts receivable, goodwill impairment, and acquisition-related intangible assets, since these judgments can materially affect reported earnings and balance-sheet values. - **Revenue recognition and payer estimates** — Net revenue and accounts receivable - **Timing of pharmaceutical vs. nursing revenue** — Quarterly revenue timing - **Goodwill impairment** — Potential non-cash impairment charges - **Accounts receivable collectability** — Bad debt and working capital - Revenue depends on estimated net realizable amounts from payers and patients - Pharmaceutical revenue is recognized on delivery of goods - Nursing service revenue is recognized when services are rendered - Goodwill is tested annually for impairment and can create non-cash charges - Accounts receivable and payer collections depend on reimbursement estimates --- *Last updated: 2026-04-29T04:44:14.521666+00:00*